Sign In
Buy VIVO
$3.90
+0.170 (+4.56%)
At Close: Aug 04, 2026
Meridian Bioscience: Good Stock, But Margin Of Safety Required
04:02pm, Friday, 09'th Apr 2021
Meridian Bioscience benefited from a windfall due to the Covid-19 pandemic, resulting in the growth of its Life Science segment.
4 Lucrative MedTech Stocks to Bet On in 2021 Amid Pandemic
09:51am, Thursday, 01'st Apr 2021
Grab these four top stocks, HRC, OMI, MCK and VIVO, which continue to show promise amid the pandemic and can turn out to be wise investment choices for 2021.
Has Meridian Bioscience (VIVO) Outpaced Other Medical Stocks This Year?
12:06pm, Monday, 29'th Mar 2021
Is (VIVO) Outperforming Other Medical Stocks This Year?
8 Small-Cap Stocks With Plenty of Cred
11:34am, Monday, 29'th Mar 2021
These eight small-cap stocks are affordable, and they can deliver significant returns, especially during an economic recovery. The post 8 Small-Cap Stocks With Plenty of Cred appeared first on Investo
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Meridian Bioscience, Inc. - VIVO
03:05am, Wednesday, 24'th Mar 2021
NEW YORK, March 24, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ: VIVO). Such investors are ad
Week 12 MDA Breakout Stocks - March 2021: Short-Term Picks To Give You An Edge
04:13am, Monday, 22'nd Mar 2021
Two new breakout stocks for Week 12 of 2021 with better than 10% short-term upside potential.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Meridian Bioscience, Inc. - VIVO
09:54pm, Sunday, 21'st Mar 2021
New York, New York--(Newsfile Corp. - March 21, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ: VIVO). Such inv
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Meridian Bioscience, Inc. - VIVO
04:58pm, Thursday, 18'th Mar 2021
NEW YORK, March 18, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ: VIVO). Such investors are
5 Must-Buy Efficient Stocks to Make Your Portfolio Stand Out
07:35am, Wednesday, 17'th Mar 2021
Crocs (CROX), iRobot (IRBT), Sprouts Farmers Market (SFM), Meridian Bioscience (VIVO) & MEDIFAST (MED) are the top five companies boasting solid efficiency levels at present.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Meridian Bioscience, Inc. - VIVO
09:46pm, Sunday, 14'th Mar 2021
New York, New York--(Newsfile Corp. - March 14, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ: VIVO). Such inv
Has Meridian Bioscience (VIVO) Outpaced Other Medical Stocks This Year?
12:31pm, Friday, 12'th Mar 2021
Is (VIVO) Outperforming Other Medical Stocks This Year?
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Meridian Bioscience, Inc. - VIVO
06:00am, Friday, 12'th Mar 2021
NEW YORK, March 12, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ: VIVO). Such investors are a
Meridian Bioscience's (VIVO) Shares March Higher, Can It Continue?
09:51am, Thursday, 11'th Mar 2021
As of late, it has definitely been a great time to be an investor in Meridian Bioscience, Inc. (VIVO).
Meridian Launches its New Air-Dryable Mix for Crude Blood Samples
10:00am, Monday, 08'th Mar 2021
CINCINNATI, March 08, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today the l
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Meridian Bioscience, Inc. - VIVO
06:02pm, Sunday, 07'th Mar 2021
New York, New York--(Newsfile Corp. - March 7, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ: VIVO). Such inve
